Cancer patient disclosure and patient-doctor communication of complementary and alternative medicine use: a systematic review
- PMID: 22933591
- PMCID: PMC3500370
- DOI: 10.1634/theoncologist.2012-0223
Cancer patient disclosure and patient-doctor communication of complementary and alternative medicine use: a systematic review
Abstract
Objective: To explore the nondisclosure of complementary and alternative medicine (CAM) use among cancer patients, including reasons for and outcomes from nondisclosure of CAM use, within the context of patient-doctor communication.
Method: A systematic review was conducted exploring investigations surrounding the communication of CAM use for patients with cancer published until August 2011.
Results: A total of 21 studies were located, which reported a prevalence of CAM use among patients with cancer ranging between 11% and 95%; of these patients, 20% to 77% did not disclose their CAM use. The main reasons for nondisclosure were the doctor's lack of inquiry; patient's anticipation of the doctor's disapproval, disinterest, or inability to help; and patient's perception that disclosure of CAM use is irrelevant to their conventional care. There is some evidence to suggest that patient-doctor communication about the use of CAM was associated with an enhanced patient-doctor relationship and higher patient satisfaction.
Conclusions: Although the use of CAM by patients with cancer is high, patients frequently fail to disclose its use to their health professionals for reasons emanating from both sides of the dyadic patient-doctor relationship. Because a substantial proportion of patients with cancer may use CAM and there is potential for herb- or vitamin-drug interactions, further research in patient-doctor communication about CAM is necessary to maintain patient safety and wellbeing. The development of effective interventions to improve the disclosure of CAM use should be an integral part of this future research.
Conflict of interest statement
Section Editors:
Reviewer “A”: None
Reviewer “B”: None
Figures
Similar articles
-
Communication Between Cancer Patients and Physicians About Complementary and Alternative Medicine: A Systematic Review.J Integr Complement Med. 2023 Feb;29(2):80-98. doi: 10.1089/jicm.2022.0516. Epub 2022 Sep 23. J Integr Complement Med. 2023. PMID: 36149678 Free PMC article.
-
Interventions for interpersonal communication about end of life care between health practitioners and affected people.Cochrane Database Syst Rev. 2022 Jul 8;7(7):CD013116. doi: 10.1002/14651858.CD013116.pub2. Cochrane Database Syst Rev. 2022. PMID: 35802350 Free PMC article.
-
Interventions to improve antibiotic prescribing practices for hospital inpatients.Cochrane Database Syst Rev. 2017 Feb 9;2(2):CD003543. doi: 10.1002/14651858.CD003543.pub4. Cochrane Database Syst Rev. 2017. PMID: 28178770 Free PMC article.
-
Conceptual framework and systematic review of the effects of participants' and professionals' preferences in randomised controlled trials.Health Technol Assess. 2005 Sep;9(35):1-186, iii-iv. doi: 10.3310/hta9350. Health Technol Assess. 2005. PMID: 16153352
-
Patient-doctor communication.Med Clin North Am. 2003 Sep;87(5):1115-45. doi: 10.1016/s0025-7125(03)00066-x. Med Clin North Am. 2003. PMID: 14621334
Cited by
-
The trends of complementary alternative medicine use among cancer patients.BMC Complement Med Ther. 2021 Jun 8;21(1):167. doi: 10.1186/s12906-021-03338-7. BMC Complement Med Ther. 2021. PMID: 34103037 Free PMC article.
-
Using the Health Belief Model to explore why women decide for or against the removal of their ovaries to reduce their risk of developing cancer.BMC Womens Health. 2018 Nov 14;18(1):184. doi: 10.1186/s12905-018-0673-2. BMC Womens Health. 2018. PMID: 30428865 Free PMC article.
-
Healthcare Professionals' Knowledge and Behaviors Regarding Drug-Dietary Supplement and Drug-Herbal Product Interactions.Int J Environ Res Public Health. 2022 Apr 3;19(7):4290. doi: 10.3390/ijerph19074290. Int J Environ Res Public Health. 2022. PMID: 35409970 Free PMC article.
-
Prevalence of drug-drug interactions in sarcoma patients: key role of the pharmacist integration for toxicity risk management.Cancer Chemother Pharmacol. 2021 Oct;88(4):741-751. doi: 10.1007/s00280-021-04311-4. Epub 2021 Jul 24. Cancer Chemother Pharmacol. 2021. PMID: 34304283
-
Physician perspectives on education, training, and implementation of complementary and alternative medicine.Adv Med Educ Pract. 2017 Jul 25;8:499-503. doi: 10.2147/AMEP.S138572. eCollection 2017. Adv Med Educ Pract. 2017. PMID: 28794663 Free PMC article.
References
-
- U.S. Department of Health. National Health Interview Survey (NHIS) Washington, DC: U.S. Department of Health; 2002.
-
- Hyodo I, Amano N, Eguchi K, et al. Nationwide survey on complementary and alternative medicine in cancer patients in Japan. J Clin Oncol. 2005;23:2645–2654. - PubMed
-
- Jacobson JS, Workman SB, Kronenberg F. Research on complementary/alternative medicine for patients with breast cancer: A review of the biomedical literature. J Clin Oncol. 2000;18:668–683. - PubMed
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical